$0.4302
-0.01-3.17%
At close: -
$0.4636
0.037.76%
After Hours: 7:34 PM EDT
Comments
Loading...
Ovid Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OVID | Benzinga
Ovid Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.140
Quarterly Revenue Estimate
$100.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$566.00K
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics | -$0.17 | -$0.14 | — | — | $148.00K | $100.00K | — | — | 05/13/2025 | Get Alert |
| OVID | Ovid Therapeutics | -$0.22 | -$0.17 | -$0.13 | 23.53% | $141.56K | $187.50K | $76.00K | -59.47% | 03/11/2025 | Get Alert |
| OVID | Ovid Therapeutics | -$0.16 | -$0.19 | -$0.20 | -5.26% | $108.97K | $87.14K | $173.00K | 98.52% | 11/12/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.18 | -$0.22 | $0.12 | 154.55% | $75.00K | $70.00K | $169.00K | 141.43% | 08/13/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.19 | -$0.22 | -$0.17 | 22.73% | $66.00K | $60.00K | $148.00K | 146.67% | 05/14/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.16 | -$0.05 | -$0.22 | -340.00% | $46.28K | $60.00K | $141.56K | — | 03/08/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.17 | -$0.19 | -$0.16 | 15.79% | $11.10K | $50.00K | $108.97K | 117.94% | 11/03/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.21 | -$0.20 | -$0.18 | 10.00% | $0.00 | $50.00K | $75.00K | 50.00% | 08/04/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.23 | -$0.17 | -$0.19 | -11.76% | $1.45M | $20.00K | $66.16K | 230.80% | 05/05/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.38 | -$0.18 | -$0.16 | 11.11% | $0.00 | — | $46.28K | — | 03/13/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.17 | -$0.21 | -$0.17 | 19.05% | $0.00 | — | $11.10K | — | 11/08/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.23 | -$0.25 | -$0.21 | 16.00% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| OVID | Ovid Therapeutics | $2.53 | -$0.21 | -$0.23 | -9.52% | $208.38M | — | $1.45M | — | 05/10/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.34 | -$0.16 | -$0.38 | -137.50% | $5.70M | — | $0.00 | — | 03/15/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.28 | — | -$0.17 | — | $6.91M | — | $0.00 | — | 11/10/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.41 | -$0.16 | -$0.23 | -43.75% | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.37 | -$0.14 | $2.53 | 1907.14% | $0.00 | $1.29M | $208.38M | 16053.72% | 05/13/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.35 | — | -$0.34 | — | $0.00 | — | $5.70M | — | 03/15/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.43 | -$0.36 | -$0.28 | 22.22% | $0.00 | $80.00K | $6.91M | 8542.50% | 11/12/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.34 | -$0.36 | -$0.41 | -13.89% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.46 | — | -$0.37 | — | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
Ovid Therapeutics (OVID) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.13 | $-0.17 | 23.5 % |
| Q3 | 2024-11-12 | $-0.20 | $-0.19 | -5.26 % |
| Q2 | 2024-08-13 | $0.12 | $-0.22 | 154.6 % |
| Q1 | 2024-05-14 | $-0.17 | $-0.22 | 22.7 % |
Ovid Therapeutics (OVID) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $76.00K | $187.50K | -59.5 % |
| Q3 | 2024-11-12 | $173.00K | $87.14K | 98.5 % |
| Q2 | 2024-08-13 | $169.00K | $70.00K | 141.4 % |
| Q1 | 2024-05-14 | $148.00K | $60.00K | 146.7 % |
FAQ
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics (OVID) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Ovid Therapeutics (NASDAQ:OVID)?
The Actual EPS was $-0.13, which beat the estimate of $-0.17.
What were Ovid Therapeutics’s (NASDAQ:OVID) revenues?
The Actual Revenue was $76K, which missed the estimate of $187.5K.
Browse earnings estimates, EPS, and revenue on all stocks.